The above information was disclosed in a filing to the SEC. Some additional info was provided as follows:
Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested.
To see this filing in its entirety, click here
To receive a free e-mail notification whenever an insider of Genomic Health makes a similar move, sign up!
Other recent filings from the company include the following:
Annual report [Section 13 and 15(d), not S-K Item 405] - March 11, 2014